Rapamycin also negatively regulates VEGF, platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF) and so on, which are transcriptional targets of hypoxia-inducible factor 1α (HIF-1α) and contribute to vascular development and cancer progression [108]. Here, HIF1A is linked to cancer.